Fingolimod Capsule
Product Images NDC 64980-449

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 64980-449). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fingolimod 01)

FDA Label Image

Figure 1 (Fingolimod 02)

Figure 1 (Fingolimod 02)
This is a chart that shows the percentage of patients with three-month confirmed progression on treatment with Fingolimod 0.5mg versus placebo. Unfortunately, there is no data available for the treatment group at specific time intervals.*
FDA Label Image

Carton 28 (Fingolimod 03)

Carton 28 (Fingolimod 03)
This is a medication package for Rising Fingolimod Capsules, containing 28 capsules each with 0.5 mg of fingolimod hydrochloride. The recommended storage is at a temperature of 25°C (77°F), protecting it from moisture. There is a medication guide included in the package to be dispensed to each patient. The manufacturer is S Lo P Co, located in China, and distributed by R Pharmacy in North Bergen, NJ. The package dimensions are 84 x 59 x 31 mm.*
FDA Label Image

Bottle30 (Fingolimod 04)

Bottle30 (Fingolimod 04)
This is a description of a medication named "Fingolimod" in capsule form, of 0.56mg and 0.5mg. The medicine is distributed by Rising Pharmaceuticals, Inc. and comes with a medication guide to be given to each patient by the pharmacist. The usual dosage is specified on the package insert, and it should be stored at controlled room temperature (25°C/77°F) and protected from moisture. Manufacturing and excursions are mentioned, but no further details are provided.*
FDA Label Image

Carton 7 (Fingolimod 05)

Carton 7 (Fingolimod 05)
Each capsule of this medication contains 0.5 mg of fingolimod hydrochloride. The usual dosage should be as indicated in the package insert. It should be stored at controlled room temperature of 25°C (77°F); however, excursions between 15° to 30°C (59° to 86°F) are permitted. Protect from moisture. This package contains seven capsules, equivalent to a one-week supply of the medication. The medication guide enclosed should be dispensed by the pharmacist to each patient. The product is manufactured in Guangdong Province, China, and distributed by Sunshine Lake Pharma Co. Ltd. in Saddle Brook, NJ. The dimensions of the package are 84 x 59 x 15 mm.*
FDA Label Image

Heclogo2 (Logo0001)

FDA Label Image

Risinglogo2 (Logo0002)

FDA Label Image

Logo0003

FDA Label Image

Logo0004

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.